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l1esponse-ildilpt.ivedesigns have been extensively stndiecl and applied in clinical trials
Howcwr,fewresei1rch is for longitndinaldataand lcss is knolVn on li Initingallocation
properties when response adaptive designs arc used in a longitndinal setting. Zhilng
d. a!. (2007) proposed a g{'lleral covariate-adjnsted n'sponse-adaptive (CAI1A) de-
sign for non-longitudinal clinical trials and explored itsasylllptotic properties. The
ohject.ives of this resei1rch arc to extend the general CAI1A design to clinical trials
with longitudinal responses, and to stndy the aSylllptotic prupcrties of the pannnl'ter
('st.illlatorsand the allocation proportion. Theexplicitl'xprl'ssionsforthelilnitingal-
locationproportionsofthecxtenclcddcsignareobtainl'd. Thegcneralizcd('stilllating
cqnationsilndlnartingnletheoriesarenscdtodevc!optheasynlptoticpropcrticsof
regression parallletersilndallocation proportions. ThisrescaI'chisalsothelirststlldy
on covariate-adjnsted response-adaptive design with longitndinal clinical n'sponSl'S
<Indwithlllorethant\\'ocolllpctingtrcatlllcnts.
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Chapter 1
Introduction
Thi~chaptcr intrudnrc~ the hackgwnml ofresponse-adaptiw dcsigns of clinical trials,
and giv('s a hridrcviclVofsomc important 1V0rksthat have he('n doneinthislil'ld
1.1 Introduction to Response-Adaptive Designs of
Clinical Trials
"A clinical trial is hasically an cxperimcnt designed to cvalnate the heneficial and
adverse efferts ufa new medical treatment or intervention."(lIosenlwrger and Lachin,
20(2). The fucns of this resParch is on clinical trials that aim at conlpnring twuOl
Inure treatments, where agTonp of new therapy trC'atedsnbjects nlaY he compared to
agronpufconventiunal t.herapy t.reatedsubjectsoragruupofsnhjedswhoreceiw
aplacehucontrol
Randomizat.ion isafnlld'l.Incntnl principlethat.llils been IViddyapplicd throngh-
uut. t.he design, cunduct and analysis of clinical t.riab The Ilse uf randonlizat.ion
s('rwss('vcmlilllportantpmposesinaclinicalstndy. Itpreventsallocatingpatil'nts




gronpdifferpncelmgclYllnalnbigllolls (Brianalld Andrew, 19!.J9)
Howcver, ralldomizedclillical tria!s,tlsocreatc llluchcontroversy. The 1ll0St. dwl-
kllgillg issllc is thc d.hics of rnmlolllization. Response-adaptivc designs werc dewl-
oped as onc oft.hc sollltions t.o thiscthical issue, and haw beenwidelyst.lldil'd. The
followingspctiollswillfmt.herdisclIsst.hel'thicsofrnndolllizat.ionandthedevploplIll'lIt.
ofrespolIse-adapt.ivt'desigll
1.1.1 Ethical Issues in Randomized Clinical Trials
Ethical issllcs gencmlly exist. t.hrullghollt. t.he design, cundllct and analyze of clinical
trials.whilerHlldOlni:r,atiollisoftpnidentilicdasthcccntralct.hicalisslleinclinical
trials which relatesdircctly to the statistical aspcctsofdesign ami allalysis. 13rian
alld Alldrew (1999) illllstrated the potential risk of employing randomization to as-
sigil part.icipallts ill clinical trials through the exampll' of IIsing:r,ido\"l)(line (AZT) to
treat AIDS. \Vhpn thl' trials of AZT as a tll('rapy for A[DS "wcre first annollllced,
there was a large, vocallobhy against testing the drllg in a controlled clinical trial
whcrenecessarilysolnc patient.swollldn'ceivean·inferior t.reatlnl'lIt'. Later, hOW('VN,
when thes('Vl'rityo[solllcsidedfeds was idpntified and the long t('rm dfl'ctivl'npss
of thc drllg in dOli ht., 11.n eC(lIally vocal lobby calk'd for AZT t.reatment to he aba.ll-
donPl\' Expanding networks of 'support group~' nlnkps thE'~p problpnl~ inlTeH:-;iugly
likely."'(Briau and Andrew, 19!!9)
Thi~ pxalllple ~ho\\"s the IlI1certaiuty of treatllleut eft"ect~ in clinical triab. aud the
concern of adverse illlpach on patieuts who participate in the study, \\'hich revpal
the lIIajor problelll~ exist iu l"iludolllly n~signing p'ltients to treatllleuts in a stll<h-
\Vhl'U lIsiug probability as a IIIPthod of assiguing trcatlllcnts to patipnts in clinical
trials for randOluization pmpose, it gives patients a dHlnce of being a~signcd to a
potentially eH'ectivp treatnlPnt, bnt abo a chance not to rpceive a trpatlllcnt which
nlight potentially he VCIY beneficial or Illiss the be~t tilllc' for receiving trPat,lnents
In addition, itl'xposcspaticllts to the risk ofrecciving a tr('at IncntwhichnlitytllrJI
Ollt to he highly toxic. This concern i~ r('ferred to mi "individlli\ll'thics" (SchwiH"tz
alld Lellollch, 1971), the goal of which i~ for individual patients to recpivp thc bcst.
possibletreatlllent.
O('spitpnot brillgingindividuab their Iwst inten'st, nlndolllizedclinical trialshavl'
beeu PIIIIJnlCpd by Ino~t of today\ scientiHts. Since WhPll takiug iuto cousidl'l"iltion
of "collective pthic~" whcre to find the best treatlllent for the entire pati('ut group is
of conC('["ll (SchwiH"tz aud Lellouch. 1971). the fnct that l"ilndolllizatiou cau providl'
a solid foundation for iuf('rencc of treatlllent pffect~, thus l('ading to a scientifie COIII-
parisolloftreatllll'llt('H'ectsandlheadvallceluelltofpnhlichl'althisvpryiuqlOrtaut
to om society,
Tonchiev(' the balance between "iudividnalethics"and "collectiveethics" iSIHltU-
mllychalll'nging, and is still thesubjectoflllauywseilrchers. As one ofthc aHl'lnpl's
to solve this pl'Oblclll, information ofaccullllilated rL'sponses in a clinical trial is Ils('d
toskewtheassignnll:ntofflltmepatientsint"avolll'oftl1l'treatnll'ntthatsofmhas
a "I)('tter" performance, fle~pon~e-adaptivedc~ign~ w('re tlulti propo~cd,
1.1.2 Development of Response-Adaptive Designs
fle~pon~e-adapt.ive rnndomi~ation i~ developed as an eHort to mitigate the ('onAict
between"individnalethieti"and"colleetive(,thics",lnaretipOntic-adaptiveritndom-
ized trial, "the probability of being a~signed to a treatment i~ changcd throughollt
thetrialaccordingtodatawhichhavealreadyaccrnedabolltthetr('atmentl'H'cct.."
(flotienbergerand Lachin, 2002). The goal ititoatitiignlnor('patient~tothe pot('ntially
"better" treatment for the bendit of "individnall'thicti", while the allocation proce-
dme is still fnlly randomized for the inference of treatment dfl'Ct which willlwnl'lit
the "collective ethicti". The early work on re~pon~e-adaptiVl'd('~ignti may be traced
back to the play-the-winner rnle by Zclen (HJ69). The work con~ilic'rcd clinica.l trials
with two trcatl1lentti. The incoming patient's ati~ignment depclllls on thc I'l'sponse of
the last patient in the ~tndy, If it was a sncce~s, the incoming patient is assign('d
to thes'lIne treatmcnt, otherwise, to the opposite treatIncnt. Howev('r, tlll'rc (ksign
introdncPti seic'ction biascti. To d('al with this issne, diH'ercnt alloc,ttion proc('dml's
have been proposed by many ~cholars, alllong which t,,'o major approache~ hav(' I)('('n
broadly studied
The fir~t approach i~ ba~cd on an intnitive mic to adapt thc allocation probabiliti('s
whcnassigningncwpaticnttoatreatment, which is not designed totargetsolne
specific a.llocation proportion~. It is cOlllpletely nonparalnl'tric bnt is nut considered as
uptimal in it formal ~en~c. 11 [ost designs nsing this approach arc rl'itlizcd ill thl' C(lIltl'xt
of varions nrn modl'ls (Hn and flosenbergcr, 2006; flosl'nbcrgcr and Lachin, 2(02)
Wei and Durhanl (U)7 ) propo~ed the randomizl'd play-the-winner mle basl'd on
Ze!en's research (l9G9). The t\\·o competing trl'atment~A and 13 are each repn'spnll'd
by 11 ball~ in an mn. A ball i~ drawn and replaced. Patient is as~igned to the trl'atIlll'nt
representl'd by the ball. Asncce~swill resnlt in {3,(13 > 0) balls representing the Sillnl'
trl'atment a~ the patient I\"i\S a~~igned to added to the nm, a failml' will rl'snll in
(I.UJ > 0) balls represpnting the opposite treatment being added to the mn. Thl'ir
designskewstheprobabilityoftreatmentassignmenttofavort.hepotl'ntially"betll'r"
treatment, rnthl'r than switchingdeterministically betwpen trl'atml'nt.s as in Z(,len's
(lOGO) play-the-winner 1"11 le. Athreya and I<arlin (l9G8) proposed the gennaliz('d
Fril'chwlIl's n1"1l modclwhich is a natmal design for clinical trials with I< (II" 2': 2)
trcatml'nts. Thc'lllocationofincomingpatientdl'ppndsollamndomvmiablewhose
distribntion isrC'lated totheprevionst.reatmentassignnll'nt. Wl'i (l979) fmthl'r
explored the generalized Friedman's nrn model and propospd asimpleallocationmle
based on the original work. Some other popular designs are the birth anddeathmn
([vanova, f!osenbl'rgl'r, Dmham, et al. ,2(00), and the drop-the-Ioser mle ([vanova.
2(02) in which atl'nmy urn modcl is nsed and thevariabilityofallocationproportions
\\"a~ prOl"ed to attnill the lower bonnd of the variance of allocation proportions. (Hn
eta1.200G)
The second approach is based on parametric models and designed 10 target thl'
allocation proportion before the start ofa trial. The target. allocation proportion is
a fnnction uf parameters which represent the treatment l'ffects. f!l'sponses ofseqnl'n-
tiallyncCl"nedpatil'ntsnrensedtollpdateestimatesofnnknuwnpammetl'rsinmost
designs. This il.ppl'Onch isuften refereed tu ilssPC/nential pstimation procl'dml's (Hn
and f!osenberger, 200G). To obtain nn initial eshInate ofnnknown parilInetl'rS, sonll:
data must b('1\vailablctocompute the ('stillmt('s. III practice, asequelltia]pstimatillll;
trialllsllally I)('gills with a c('rtaill IIlullher of pati('uts assigu('d to each tTeatull'lIt
I)('for(' the proposed proeedme b('gins. :'Ilelli and Pag(' (1995), and i\ldfi. Pag(' and
Geraldes(2001) ('xploredprop('rti('softhe sequential 1Ila.:ximlllnI ikelihoodpro(whlr('
targeting the N('yman allocation ddined by the ratio ofth(' standmd deviations of
twoeomp('ting tr('at.m('nts. Jennisonand Tmllbllll (2[)OO) propos('d agroupSl''1nl'lI-
tialadaptivedesign totmgetingapredcfillcdoptima.lallocation ratio forthl'diff('r-
l'lIce of 1I0nllalmeans. Eisele (1994), alld Eiscle and Woodroofe (1995) proposed a
donbly-adaptivehiasedcoilldesigll to achieve any desired <lllopatiollproportiollwhclI
cOlllpming two treatlnl'lIts. The doubly-adaptive biased coill design yil'ids a large
family of s(''1l1elltial estinmtion procedur('s. RII alld ZhHng (2004) gelleralized thl'
design to mlilti-tr('atment cas('s, alld derived the strong cOllsistency alld asynlptotic
lIormalityofthedesignulldersomewiddysatislkdeollditiolls.




complexity ofmodertl clinical trials grows, adaptiv('desiglls 1111spd solely 011 patiPllts
n'sponses to tn'atlllents me illadequate to address IIl1iqne covmiate stnlctnn's UII-
dprlying pach patiellt.s's progllosis. The covmiatc illformatioll associated with l"lt"h
patil'lIt may havestrollgiIlHuencesoncolllprl'hl'lIsiv(,l'valnationofth('('H'I'ctivl'II('SS
of trl'at.lllents For I'X'Ullpk, t.he dfectivcllcss of asthllla tn'atllll'nt may dqll'lId Oil
whrthertlw patient is aSlllukerur non-slllokerand whichagegronp thepntient
helongs to. The coviU"iate-adjnsted response-adaptive (CAIIA) designs an' thus in-
trodnceo
lIosenbergeretal. (2001) firstly nsed a lugistic Illodcl to incorporatecovmiates int0
the allocation schl'llle. Even though they did uotgiwauytheoreticaljustificatiousilnd
asynlptoticproperties, theirsilllulatioustuoyindicated that theirapproach,togethl'r
with the iuclusiou of the cuvariates, siguificautly reduced theperceutageuftren.tul('ut
faiI lIres. Bandyopadhyay et a1. (2007), oeveluped a two-stagt' allocatiou rule fur
binary responses incorporating covari"tes. They showed several exact and lilniting
propcrties for the proportion ofallucation and treatllleut failllres in their work. Zhang
et al.(2007) laid ont a fralllework for n.general CAIIA design, which canl>e applied
to clinical trii1b tocolllpnre"- trcatl1lellts (I,- 2: 2) and aresnitable for both discretf'
andcontilulOUS responses. ASYUlptotic properties of this gent'ral CAIIA designundel
certain widely sati·fird conditions have alsu hern studied.
Ashavehef'ndiscnssed,exteusiveresemch have hl'en conducted towards response-
adaptiw designs. Howl'ver, the methodology discnssed ahove me only snitahle for
clinical trials in which responses me ouly ohserved ouce. WheuthereSpOllSl'sofeach
patielltme rq)l'atedly recorded through a certain period oftilne, 1ll0rl'cOlupkxit.y
me added. The following discussion ison respouse-adaptivedt'signswith lungitudinal
1.1.4 Response-Adaptive Designs with Longitudinal Responses
The re~ponses of pntients lIlay often be observed rpppatedly O\'pr diH'erent Inonitur-
ing tillles which Inake the data of responses longitndinal in natm!'. For l'x'lInple, a
rilndulllized clinical trialwa~ condncted for treating dmg addiction where h\"O trent-
lIlents (Bnprenorphine and i\kthadone) were cOlllpmed for their ability to rednl'<'
opiat.e use H1nung a group of lG2 addicts (.Iohn~on n E. et aI., (992). The ontcOlne
of thi~ trial i~ a vector of repeated binary responses of whether an individnal failed
amine test at each ofJ visit.s per week (on Monday, Wl'dnesdayallll Friday)owr
a 17-week period. The rr'a~ons for collecting 100lgitndinal data in clinical t.rials me
to obtain a 1Il0re preci~e estilnate uf t.he untconte and hpnce the tn"t,tlllpnt pH'pct or
to evalnate t.he treatment eH'ect owr tinle (Albert P., (999). Th('l"efore, if repented
rp~pun~e~ are n~ed in response-adaptive design to tlpdate the allocation probability of
theincolllingpatient, intnitively it wonld be 1Il0reellieient to assignlllorepatipntsto
the potentially "hetter" treat.ment. However, thi~ ~et.np i~ n~ually cOlllplicatpd due to
the correlat.iou wit.hiu the longit.ndiual re~pou~e~ of each patient. and Ihe dp!lt'llllpUl'y
result.~ from t.he adnpt.ation of treatment allocation, The literatme in lhi~ case i~ abo
scanty
l3iswa~andDL'wanji (2004) dewloped the longitndinal rilndolllized play-t.he-wiluler
(LRP\\") mle, which is iln mn design that pxtends the r<lndOlnized play-thp-winnel
(RPW) mic to acconnnodate longitndinal binary rl'sponsps. l3iswas and DL'wanji
(200-1) applied this dpsign 10 invest.igalp t.he effect of pulse e!ecl,ro-lIlagndic lipid
(PEi\IF) for the treatlllent of pati,'n(,s wit.h r1telnnn,t.oid nrt.hritis in the st.ndy con-
duct.ed in t.he Indian Statistical [nst.it.nte, Kollmt.a. The design successfttlly 'lssigns
1lI0re p'1tipnt~ to the better pNforllling trPat.nlPnt. 1-I0Wlo'vPr, thl'Y did not considl'!
the available covnriate~ ~I!ch a~ gpndpr or age which llIay havp significant.ly inHnpncl'd
thp treat.llIl'nt ('!fects and the allocation pr<Jcedml' of the design was rc'strided to
clinical st.ndies with only two conlpeting t.rea.t.nIPnt~. Sntradhar. l3iswas and l3ari
(2005) introduced a binary response-ba~ed longitndinal adaptivlo' design. They nti-
lized a silllilar allocation rnle as the LRP\V, bnt proposed a weighted ge!H'ralized
qnasi-likelihood (WGQL) approach for the con~i~tent and ellkient estilllation of the
regression parallleters including the treatlllent effect~. Snbseqnl'ntly, Sntradhar 'lIld
Jow'1he('l"(2006)appliedWGQLapproachtoanalyzPlongitndinalcountdatailCtTued
in clinicn.l t.rinls. However, tlH'~e dlo'signs still did not go beyond th" LRPW mll' of
l3iswfl~ and Oewflnji (200-1), and the current patient.'~ covariate were not. consid"red
in the allocation design. The l'xten~ion of alloca.tion procedure to clinical trials with
1lI0rethant\\·ocolllpetingtreatlllentshadnotb('('nstndied.
l3iswa~ l't al. (2010) considerpd dinical triab with two cOlllppt.ing treatlllcnts and
proposed acovariatp-adjusted longitndinal response-adaptive (CALflA) dcsignllsing
t.he log-odds ratio within the Bayl'sian fmtncwork. Their nmin allocat.ion sdlenle
is as follows. First, a totalnlnnber of patipnts in the tria.l N is fix"d b"for" t.he
study IH'gins. To bf'gin t.he adaptive process, 2/11 (11/ E N+) pati"nls were assigned
('qnally to the two cOlllpeting treatments n~ing ,t rcstrictl'd randolllization prDcl'dme
at thelir~tstage. Thesf'condstage involvps the rentaining (N-2111) patients. dming
which patients with covariatc vpctor X is assignf'd to the defanlt lrc'allncnt with
probabilitYIJ=P(X). Theallocutionruleisa.l"tlnclionoft.hecovariateofthpincolning
patient, and is based on all the available data lip to t.hat t.illle point. To dct('r1ninc'
!I(X) appropriatdy, theydclinl'anut.ilit.yfunetion basl'don the likelihood fUllction
ofthc availahle inforlllation. The correlation within thc- rc-sponsc-s ofc-ach sllhj,'ct
are a.ssnlllcd to follow an AR(l) structure. l3y Illaxilllizing the ntility fnnction, the
allocation fnnction of the incollling patient p(X) is ,kterlllinc-d. Tht, CALRr\ ,IPsign is
the firstoptilllal design in clinical trials with longitndinal r('sponsc-s. It also Inanagc-d
toincorporatccovariatc-inforlllationofthecmrentpatic-ntintoalongitndinalresponse
setup and ohtained its statistical properties throngh sonleoptilllalitycriterion
Howcver, this dc-sign e,lll only he applied to clinical trials with two cOlnpeting
trpatlllcnts, and it only dc-signed for clinical trials with hinary n'sponsc-s. Th('condi-
tionon IIsingthisdc-sign is too restrictive tOgf'nNate tOlnoregc-n('ralcascsorothcr
types of responses. TheCALR.A design also does not ha.vc an ('xplicit expressioll for
thevariabilityofthcdesignnllocationallll thclilllitillgnllocation proportion. Olllya
nlnneric stlldy and an exalllplc on the effect ofplIlsed clect.ro-nlagnetic field (PEf\lF)
forthctreatlllc-lItofrhelllllatoidarthritiswercprovidc-dtoillustmtetheeffectiven('ss
of the CALRA design
1.2 Objective of This Research
Thc ohjc-ctives of this research are to extend the application of the general CARA
dc-signtoclinicnltrinlswithlongitudinalrc-sponsesandtostlldy thensylllptotic prop-
('rtipsaswellaslogivpexplicitc-xprc-ssionsforthelilllitingallocat ion proportions of
tbe extended desi)!;n. Thc genNalizc-d c-stilllatinge'lllations and Illartingale theory
arcnsed to develop theasylllptotic propertic-sofn'gression panullctersall(! allocation
proportions. This rc-search is also thc first stndy on;, covariate-adjllstpd n'spons('-
ndaptivcdesigllwith longitlldinaln'sponsesnnd IlIorethan twoconlJwtingtrcatlllents.
Chapter 2
General CARA Design with
Longitudinal Responses
This chaptcr is dpvotpd to extend the application of the g('llpral CAI\A design (Zhang
et al.. 2007) to clinical trials with !ongitndinallT'sponsps. In s~'chon 2.1, we dpscrihe
the framcwork and asymptotic propcrties of thc gl'npral CARA design. In spdion
2.2, WP give the fnulll'work and the gcncral data setnp in the longitudinal clinical
trials. rn section 2.3, the proposed allocation procedllre for longitudinal clinical trials
isintrodncl'd.
2.1 Introduction to the General CARA Design
The gencral franll'work of thc CAIIA design is introdnced by Zhang et al.(2007) and
isreprodncpd in this section
Zhang et al.(2007) considered a clinical trial with [( treatments. Let Xi he
the r<Lndol1l trc'atnlcnt assignment for the if" patil'nt (i = 1,2, . ), where Xi =
(.I"il ··.l"il····.I",j,·). [fa pa(il'nt iH assignl'd lo lrl'at.lllent. k (k = 1,2... ,[,'). tllen
I"ik = 1 "'hill' .r'j = 0, (j of k.j = 1,2, ... , [,'). Ll'I. N,~' be thl' Inllllber of snbjl'cts
assigned t.o the kilt treatnll'nt. alllong the firHt. n pa(il'ntH. Write ,,= (N,~, ,N,~·).
t.hen ,,= L;~, Xi. The observl'd rl'sponsl' of a patient aHsignl'd to t.hl' kilt treatnll'nt.
is dt'not.l'd as li·, t.lle covnriatl' vector of WhOlll is dl'not.ed as ~ The rl'sponsl' and
covariateV{'ct.orarl'snppOSl'c\toHatisfy
(2.1)
Whl'rl'pl'(-,'), 1.:= 1,2, .. ,[,', are known flnlct.ions, and fh arl' Iluknowu parallll'll'rs
Tlleseqnence {(Y,,,,,, ,y,,,,/,,~,,,),II/.= 1,2, ... } isasslunl'd t.o be indl'p('ndpnt. and
ideut.ically dist.ribnt.ed as t.hat. of {(YI , •.• , Y,,·,~)}
To st.art., a rl'st.rictl'd raudonli~at.iou is USl'c\ t.o aSHigu 1110 (1110 E N+) pa,!.il'nt.s to
l'ach treat.llll'nt. Assluue that /1/(111:::>: /,'1110) pat.ieuts lIave nlready been assigned to
t.reat.llll'nts. Ll't. Bm bt' t.hees!.illlateof8 at that. stage. Whl'u till' (1IL+1j1" pitlil'llt
is ready to l'uler the study, the covariate of WhOlll ~m+1 iH I'l'corde<! aud the patil'ut
will be assigned to tl'patnll'Ut. k with probabilit.y
wlll're Fm = a(X I , ... , X"" Y I , ... , Y"" ~" ... , ~",) is till' sigllla lil'ld of till' history
aud 1I'd"') arl' sonic givl'n fnuctious that. sat.isl:y 0 < 11'1'(-") < 1 for eaI'll k, illld




g((}) = C'll((}) ... ,!/I{((})) (2.-1)
(2.5)
Under the assumption ofthl' continuity ofthl' allocation fnnction 7l"((},~). ZlulIlg d
al.(2007) dl'rivl'd thl' following rpsldts. If for l'ach trmtmC'llt k (k = 1, ,1,"), thl'
pantmetcr estimators satisfy the followingl'qn<\tion
allocatiou proportion for the k'lo treatment hns a limiting valne of u,.. For patients
with certain specific l"ovariates ~', t.he limiting allocation proportion to treatment k
iS7rkU3,C). Theconvcrgcnce ntte for the allocation proportions and thl'est.ilnators
of par1\lneters are 0 (~). Thp allocation proportions and the estimators of
pnntllletcrshothhavensymptoticallylnnltivmintenormaldistrihntions
Zhangctal.(2007) examined alargeapplicablecascwhl'regenl'ralizedlinei\l" mod-
els arp nsed in the cstilnation of regression paraml'tl'rs for the l'xponl'ntial fnmily.
Theydl'fined
information matrix. ffI;.arenonsingular. then nndercertaincondi tion,t.hensymp-
toticvarinncpofthedcsignisVk=IZ 1
TOl'xtl'nd their work t.o t.he longitudinal clinical t.rials, we\l('cd tosetnpafl"i\llle-
work for lungitndinal dat.a in addition to thpiroriginal notn,t. ions.
2.2 Longitudinal Response Setup
Let Xi = (.1'.1 ...1',,, ....1',,,.) be the treatment atitiignment for the i '" patil'nt. Let
Y7' = (Ill'" 11:r,)' 1)(' a T i x 1 vector which denoteti the responses of the i l " patient
allocated to the 1.-1" tn'atinentcollccted ovprTi diH'erent time points
Assume there arc jJdilferent covariates ponsidered in thecvalnation ofpatipnls'
respontie, let ~'i = (~il'" ~it··· ~iTJ' be the Tix/J n\;\.trix that denotps the l'Ovariates
of t.he i '" pat.ient corresponding t.o t.he T i diH·erent. coll,~cting t.ime points
\,yit.hout.loseofgeneralitY,weaStilnneeachpatient.'tirespontil'sandcovmial'I'ti
merepeatedlyl'xanlinl'dandrccordedfort.hesil.lnelixedt.inll'sdenot.cdatiT.i.C'.,
T; = T, (i = 1,2, .. .). The t.ime int.erval I)('t.wl'en all t.he patient.ti' l'xi1.lninat.ion ,Irp
I'qnallyspaced, and Wl't.rl'at.cd it. atiaunit t.inle. Thitiiltitilnnpt.ion iti reasonable whl'n
dl'alingwit.h rl'allife problems. Since most. ofthl' time, wewonld prderconlbining
the same amonnt of information from each individnal to draw conclnsions abont
treatment dl'ectti in dinical t.riab. nbalanced information from dilfl'rent. individnal
may resnlt. in biasl's.
Patientti arc asslnned to seqnentially enler into Ihe st.udy. Patieutti' first covmi-
at.Pti areobservpd I'wry time right bpfore t.heyl'uteriug thc t.rial, iUld their 1()lIowing
covariatl'silrcobsl'rvedatt.hesalllctilllepointatitheirl'l'peatpdrl'tipontil'slH'ingob-
sl'rvPd. Patil'nts' n'sponties mp also atisnmed t.o IlP able to IlP colll'l'ted inlml'diatl'ly
after they arc assigned t.othc treatment. and arter they arp rl'(Jeat.l'dlyl'xiIlninl'dovl'l
diH'erentt.imepointti
[ll'sponsl's frolndiH'erent patil'nt.s are atislnnl'd to IJI' independent.l-!owe\·l'r,thc
I'I'SPOIISCticollcdcdovprdilfcrenttilnepoint.tifrolnt.hcsalllcpatil'nt arc usuallydl'-
pelldellt.. Theeorrl'latiollslJ<'twel'lIrpspolIsesofl'achilldividllalilltrodllcp Illuch COl 11-
plicatiou tothl'statistical illferl'uce for ther!l'siglls. Vmyill)!;frolll differeut problpllIs
1I'(·medl'alingwith,thccovariatesofeachpatient.ntdifferl'lIttilllepointlllaych'lngl'
thronghtilueorluaystaythesallleascollcctingtilllepoiutchanging.Silllilarly,\\'e
ilssullle that thecov'lriatl's frolll differeut patiputs me indqJ<'ndent, and thl' covari-
iltl'scolll'ctedfrolllpachpatienthaveanilldepelldl'lItalldidl'lIticaldistribntionasa
known randolll vari'lble ~ = (~1"'" ~T)
Supposegiven~,,(t = 1,2, ... ,T). that the responseofatriall.o the trpatIUl'nt k
(k = 1,2, ... , !,") at llteasure tillle poillt. t U{" hasa 11Iargillilldpnsityill all Pxpollpntial
falllilywit.hthpforlll
1 vector of IIlIknowll parillllet.l'rs. e k c IRI' is the parHlllet.f'r space of {3'.. Write
possibly IInkllown scalp panllnetl'rS
2.3 Allocation Procedure of the General CARA
Design with Longitudinal Responses
\,ye cOIIsider clinical triab where patiellts Sl'(pll'lItially (,1It.<'r the st.udy. For thl' alh,-
catioll of pati"lIts, Wl' 11Iodify the schellle liSI'd ill the )!;('lIcrHl CAHA desigu to 'ldapt
t.ot.hl'lollgitudillaldatasl't.ting
First., assigll';o patieuts to ('ach tr('aJlllt'nt by IIsillg a rest.ricted rH.lldolllizat.ioll
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andcollectT tilllcsresponsesand covariatesofall patiellts. Assnllw that i(i 2: [,'io)
patieuts havealn'arly heCllassiglled totreatlllents. By the tillle the (i+l)'" patient is
ready to be assigned to a treatlllent, the covariates of the (i+l)1" patientareohs<'rVl'd
for the first tilneallddenotedas~i+l,l' Until th<'ll, therespollspaudcovnriatesofthe
i,l, patiplltnreonlyohservedonce, whichnrcrecordedasY;' = (ill)'( /;=1,2, ... ,1\')
and ~i = (~il)'. The responses illld covariates of the (i - I)'" patient only have
1,2, ... , [,') and ~'i-l = (~i-l,1'~i-l,2)' respectively. Iu general, the responses 'Hid
eovariatesofthe(i-t+l)'" patient hythetillletheU+l)'" patielltellteringthe trial
have t (t = 1,2 ... ,T-li\(i- Kio)) repeatedly llleasured records denoted as Y~:""+I =
(!J~:""+l.I,···,!J~:""+I.r+l),(k = 1,2, ... ,1,') and ~i-t+l = (~i-t+l,l""'~i-t+l,t+l)'
for responses and covariates respectively. If U- io) 2: T, theu the first (i - T + 1)
patieutswoHld havetheirT tilllesrepeatedlyobserved respousesandcovariates.
After the (i+ I)'" patient is assigued to atreatlllellt, the rpsponseof ,dlOlU will
he observed for the first tillle alld recorded as Y~~I = (!Jf+I.I)' The responscs ilud
('ovariates of the previoHs (i-t+l) (1:::: t :::: T-li\(i-io)) patieuts will he observed
ilndrccordedilg'liu.
Usually. Tisslllall hilt the total ulllllber of patiellts 11 iu atrial islargc. i.e .. whell
11. is large.oulyTpatieutsdouot havecolllpletelyrecorded rcspolIsCSillldcovmiates
beforethei'hpaticntelltcringthetrial,illldthisllIlllIherisslllalll'UlIlpnrcdtothe
Inllu!)('r ofpatif'nts with fllllyT records. Therefore, for notation sinlplicity, wc still
IIse Y7:...'+1 and ~'i-t+l to denote the respOllseS and covariates of t.he (i - t. + 1)'"
patil'nt. The dil-t'erence is when T - 1 < t < i, Y7:...,+1 is a T x 1 vector and ~'i-t+l is
a T x I' llJatrix, whereils when 1 :::: t :::: T - 1, Y7:..., is a I x 1 Vf'ctor and ~i-t is a t x t'
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IlIat,rix
LctFj = a(Yl,Xl'~l"" Yi,Xi'~i) be thesiglllafield gellt'rated from theelltire
hi:;tury of all previolls paticllt:; before the (i+1)lh patiellt (,Iltrrs the trial. LI,t f/
beallestilllatpuf{3"(1.:=1,2"",[\"), which is based 011 theobscrvpd rcspoll:;p:;alld
their COITcspolldillg covariates iHIlOllg those previous i patiellts who were assiglled to
treatlllcllt k, Thell fJi = (fJ;/, ... ,fJ;</) is all estilllate of {3 = ({31/, ... , (3KI) l){'for('
the(i+1)tI'patielltellterillgthcstlldy. Sllppusethatthe(i,+1)tll patielltisassiglled
to treatlllrllt k with probability
whprr 'lrkC, ,) me SOllle givell fllllctioll:; that sati:;ty 0 < 'Ir,(,,') < 1 for (';lch k, ami
L:~I 'Ir"C, ,) = 1. We Ilse the sallle Ilotatioll as that ill Zhallg et al. (2007), alld
refer the vector fUIlCtiOIl7r("') = (7rIC"),.,,,'Ir/,C,")) as a allocatioll fllllctiull. Let.
Dt'fill()





Whell{3 arc thrrral panllllt'trrs frolll thedi:;triblltiollofl'<'spoIlSesillld tbedistri-
blltioll of the covariat.es me kIlUWIl, A i:; t.he allucatioll proportioll alllullg thl' K
t.reat.llIell!s ba:;ed on theschellledescribecl above, Asdi:icllssed ill Zhallget. al.(2007),
diH'el'<'Ilt. choices of 71'(.,.) call gl'llerate differellt. classes of desigll:;,
Patiellts ellter the trial seqllelltially alld are allocated to treatllll'llts seqll('lltiillly.
The'lssigllllll'lltoftreatlll('llt to the (i+l)'h patielltdepelldsolllyoll theprl'viollsly
collected illfol"lllatiollF,'llld his/l",rcovariateS~-i+l,l'Therefore,theahove('(]llittioll
(1.-1) Cilll abo he writtell ilS
P(X,+I,k = IIF'.~i+l) = P(X'+I.' = IIF"~i+l,l) = 7i"k(.ai'~i+L,rl, k = 1,2, ... , /\'
(2.13)
The descrihed allocatioll procedure ahove will he pcrfol"llled e,"ery tillle whell a
Ilewpatielltellterillgthetrialalld theirn'sponsesHswellilsthecotTespolldillgcovari-
atcswill he Illeasllredalld rccordedcachtillle. \Nefollowthisallocatiollllll'thodlllltil
thel'lstpaticntelltnsilltothetrialalldallthf'patiellts'rf'SpOIlSCSHlldcovarit('sovcr




This chapter first illtrodllcesdifferent lllethods for longitndinaldata;lllalysis. A dp-
t.ailedintrodllctionisgivcnforthegeneralizedestilllatinge(]llations which wasnscd to
Hnnlysethelongitndinaldatainourdesign. Thecst.illlationofrl'gressionparallll't.ers
is followed. Thpn thl' H!;ylllptOtiC properties of the l'stilllators ofparillneters nnd t.he
Hllocation proportions of our proposed dl'signed arl' stndil'd. A lellllllH.and it theo-
rl'1lI arc proposl'd, t.he proofs t.o which are given rl'spectivPly. At.IHSt, acolllparison
Iwt.ween our (IPsign Hnd the general CARA design proposed by Zhang et n1. (2007)
isdiscnssed. A cOlllparison het.wpen ourdl'sign Hnd ot.her designs with longit.ndinal
rl'sponsesis Hlsodiscnssedin thischnpt.er
3.1 Longitudinal Data Analysis
The dat.aoht.nin('d frolll n longit.ndinal stndy arc chnmctl'rizl'd by t.hl' fact. that. n'-
jleatedohsl'rvntionsfornsnbjPct,t.f'ndt.ohecorrelnted. Whentheollt.colllesare
continllolls, sOllle cOlnlnonlllethods me llIixed linear lnodcl (Laird Hmi 'Ware, 1982;
Ware, 1985) and the general lint'Hr mixed-eH'ects model (Verbeke and ~rolcnl)('rgh~,
2000), The~e models ~ometilne~arc referred to a~ snbject-~peciflc(SS) models (Zegl'r,
Liangand Albert, 198), since the focus of which is nsnally on t.he response for an
individnalratherthanforthepopnbt.ion, Whereas in popnlation st.ndies, snch as in
clinical trials, where the diH'erence in popnlation-averaged response be!\\w'n ~('veral
treatments is morpofconcern than the change in an individual'sresponse,nlitrginal
models me nsnally nsed inst.ead ofa fnlllikelihood procedlll'e (Zeger. Liang '1I1d AI-
bert, 1988)
Liang ami Zegpr (1986), and Zeger and Liang (1986) developed genentlizl'd e~ti-
lIlating l'lJnutions(GEE) procedlll'e, which arc es~entially I'xtended generalizl'd linp,u
models for the ~itnat.ion of correlated dat.a, With t.he po~sible application to contin-
nous data, GEE is mo~t connnonly nsed for discrete Ineasuren,ent SI'C(npnCI'~, The
method combines estimating eqnations for the rpgres~ion parameters with nlOnH'nt-
ba~ed e~tilllation for the correlation panulletf'rS bnsf'd 011 the "working" correlation a~-
~nmption, Thelllodel reC(n ires only thecorrectspecificationofthennivmiatpnlarginal
distributions provided the prilllmy concel'll i~ on the rpgression parnmeters, not on
the cOlTelation strnct.lII'e (Liang and Zcgpr, 1986), It is assnmed that the l'ol'lTla-
tion matrix 11, thns Ri, depends on a vpctor of association pannnl'ters denoted a~
Q, The "working" correlation lIlatrix is asslnned to be of the ~Hme stl'llctnre for all
~nbjpcts which rep['('~ents the average dependence among the rc'peated ob~ervatiolls
acro~~ ~ubje<:ts
There me ~ome t.heorehcal considerations for t.he probil'lns that may OITllr in
t.he GEE estilnation procedme, Cl'Owder (1995), Sntradhar and Das (HJ!J!J) "rgnpd
t.hat t.he ~t.t'Ong diffprcncc bd,wcl'n the "working" correlation and the tme IlIH!l'r1yillg
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strnctmr 11Iight rrsult ill dlicirllcy loss of therstilllntor, nlld ill SOlll<' special cases
thrrr lIIight 1I0t he cOllsist.pnt estimator for the "workillg" correlntion. However,
sillcethe"workin/!;"corrrlationsareonlytrratedlikennisanceparnlllett'rsalldllsed
ns devicrs to snpport. rstilllat.ion of the rq,jression parallleters. they shonld 1I0t I",
lIIade a part of forlllal infrrence (tdolenberghs and Verbrkt', 2(05). The GEE nlethod
yieldsconsistt'lItt'stilnatrsoftheregressioncoefficielltsalldtheir standard errors,
t'ven with Inisspecilinttion of the correlatiollal strnctmr. Tht' luss ufdlicit'ncy dllt'
t.o the nlisspecificationufthecorrdation strncturecalllJ(' It'ssPllrd as the nlnllherof
slIbjectsgpt.slmge(lIlulellherghsalld Vt'rheke,2(05). CUllsistt'ntvmiilllct't'stilllatl's
are also available under the weak asslllllption thatawt'ighted avcrnge of the estilllat.ed
cOlTt'lationlllatricesconverges tu "fixed nlittrix (lIfolenberghs>llld Verbckc, 2(05)
\lVhpn GEE is dt't'lIIed unsatisfaetory in the casps wht'n the cUlTt'lation strllct.me
is uf intt'rest, therr are sOlnt' t'xtension of GEE IlIethods olle can tmn to, sllch 'lS
second-order t'xtensions of thrse estilllating eqllations. which are IIsllally rd"enwl <Is
CEE2 (Zhao and Prenticc (HJ90)), and altt'rnating logistic rrg;rt'ssions (Carey. ZPg('1".
nlld Digglp (1993)).
Since tll(' rrl!.TPssioll parnllleters are the prilllnry cuncrrn in this pappI". I\"{' will
Ilsr GEE lIIet.hod topstilllatt' the lungitudin<ll datacollectt'd in theclinic<l1 tri<ll. Th,'
folluwing section will give a detailed introdnction to the GEE lIIudeb.
3.1.1 Generalized Estimating Equations
Let Y; = Cl}; I , ... , ,I;;-r.)"" ht' the T; x 1 vector uf outcunll'S and ~; = (~d' , ~;,r.) hI'
thelJxT; lIIat.rixofcovariatevalllcsfor the-i'hsnbject 0= 1, ,'11.)
Thcmarginaldensityof!};1 isassnllled to he in all ('xpollelltial fillnily having thp
dPllsily
whpre Bil = h('1,,), '/" = t;..:/:3. As snch, thc first two nlOlnPllts of .'lil il!'P givPII by
(3.:2)
Let R.(a) bc a Ti x Ti symmetric matrix which flllfills the reqllirpmpnt of !)('ing a




Vi will be the covariallce matrix of .'li. cov(Yi), if R.(a) is illdeed the tl'1le correlatioll
nlittrix for theYi's. Thegcnernlestilllatillgcqllationsmcdefilledtohe
"'here D i = iJ(a'(Oi))jiJ{3 = Ai~iXi. ~i = 11i1l. 'J(~) Eqnatiol1 can he repxpn'ss('d
asa fllllctiollof{3alollehy first rcplacing a hyo(Y,{3,(p). a 11 L collsist('lItpslilnntor
of a when {3 and (p me knowlI. III addition, we replace <p by (p(Y, (3). a ilL consistent
pstimatorof(p whclI{3 is known. Thpn thcpstimatillgp((lIatioll has the fOrln
illld!:J"isthesollltionofthcaboveeqllation
Solving the GEE involves itcrating hetwepn alllodified risllPrscorillg liJrest.imat-
ing{3 nlld IIIOlllellt ('stinHttion for estimating a ami (P 'IS a fllllction of{3. Ess('lItially,
it illvolvcs the following stcps as snggestcd by Liangaml Zeger (1\.)86)
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1. Compute initial pstimates for {3, say (30' assuming indepl'ndence i>etwl'l'n n~-
peated responses first, or, ill other words, nsillgcollventiollallillear rl'l,;resSioll
2. Compllte the Pearson residnals from theeqnation bt'low i>a"ed on the cmrent
valuefor{3
The specific esti,unator of a depellds on the choice of R;(a) TII(' gl'neral
approach istoPstinmtea byasill1ple fnnctiollof
(3.7)
The valueof(p can be estimated by
(3.8)
3. l3ased 011 the above (~stimation, R;(a) can he computed, as wdl as V; from
Vi = Al R;(a)A[rp (3.!J)
4. Thl'll, givell the cmrellt estimateof{3 after m itl'rations, say (3,,,, npdatl' thl'
estilnatefor{3by
I1cpeatstep2,3,4nlltilcollVl'rgcnce
3.2 Estimation of Regression Parameters
The GEE approach isgencralizerl to the response-adaptiverlesigns lVith longitndinal
responsesinthissectiun.
Binary datailnd cOllnt data are two most common typps of respuIIsesobLlilled
frumclinical triab. [lIullrdesign.lVewillmaillly focIIsolI thpse two typpsufresponsp.
\Vellsethelongitndillaldatasetnpasdescribedinsection2.2. Theexponelltia.lfamily
wit.hthelllarginalrlellsityfnnctionilsincqllatioll(3.1)willaccolnlnodate these two
illJportant discret.e distriblltions, hinary and poisson, when </Jk are COIIstant.s. \Ve
assnllle '// = 1, k = (1,2, ... ,[,") in t.hc followillg; discnssion. The reslllt.s call he




For patients Iwing; allocated to the k'" treatllll'lIt (k = 1.2, .,[,"), we ddille a
likelihood fllnctiulI for /3'" denuted as I(Y/,J.L~I,i3k) hilsed 011 i'" pat.ipllt. information
illasillJilarwayilstheqllilsi-likrlihoodfllllctioll(Wedderhlll"n, HJ7-l). Thelikelihuod




Ri(ak ) is the '·working" correlation for the k'" treatment, and V;(a k ) i~ the vari'lnCl'-
covariance matrix of the responses from the i'" patient towanb the k'" treatnH'nt
which i~ fully characterized hy an unknown s x 1 vector panllnl'ter a. According to
Ihepropertiesofquasi-likihoodfullctiouauditsresenlblcncewiththl'log-liklihuod,






= trik~r V;-l(ak)(~k - J.L~)
=0
That is, thc GEE estimating l'quation fur f3k is
(JW)
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Onc t.hing need~ to be noticl'd i~ that the inforlllation of thl' (1/ - f)'"~ (I =
1,2 ... ,T) patipnt. is not. colllplete. Howewr, since consistency and dlicipnc.v of the
est.illlator~will not. bl' affected by the nnbalanced n'spon~es (Liang awl Zl'ger, 19 fi),
GEEt'stinlation procedure can ~till be applied.
3.3 Asymptotic Properties of the Estimators and
Allocation Proportions
This ~ection ex,nnines t.he a~Ylllpt.ot.ic propertie~ of t.he GEE e~t.illlaturs and the a.l-
location proport.ion. To shut, we fir~tly nel'd t.o givc sOllle new notat.ions and sonlP
assnlnptions
Sllppose thpre arc already 1/ pat.ients pntered the ~t.ndy, let.
(:.1.18)
for (i :S 1/), then 9, is the a-field generated by all the avnilable inforJnation of
pre\'iou~ i patients \\·hen there arc alreadv 1/(1/ 2': i) paticnts enll'red the stndy. It
inclnde~ the n'peated respOlI~e~ and ("Ovariat.es of the (i + I)'h patient. which is nut
available in Fi , when t.he pat.ient. first. f'ntered the study. Thcu. F, ~ 9i i~ tri\'ial
Thf' allocation funct.ions 1r("') need to satist~\' certain cunditious silllilar as thuse
"s~lnned in Zllllng l't al. (2007), which arc as follows
Condition 1. A.'81/,1/1,e tlwt. t.he /)(lm'lll.d'T 8/)(U'C e k ;'8 I/, !JOI/,U,[",[ ,[mnl/,in ;'1/, !RI', 11.//.11
thul the 1""11(, "/Il1.lnc fl 'is un inlp'rim' poinl of e k (k = 1,2, ,1\'). FII.d.h/;nl/,lIrc,
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1. For ""rh. ft..red~, 1rk({3*,~) > 0 'is 11. ('0'" Ii"llu.oll.s fll:wlio//. of (3*, I,. = 1,2. . I,'
2. Fm' cach. k = I" .. I,'. 1rk({3*,~) is diJj"rclIttabte with. {"('''PI'et to {3* IL//.der Ihl'
c.rpeetation, ILIII! thCH' is arl> 0 sw·h that
Apply similar notations as nscd in GEE (Liang and Zeger, 198G). Let
(3.2IJ)




If the allomlio//.lalldio//.., .mtisflf mndition /., awl fJi. i E N+ is a mllstslt'lIt ('still/(/to/





Uuder theassuulptious iu the lemula, for each fixed €, 7rk(f3',€) > () is a ('OlltiIIlIOlls
l'ullctiouof{3', k= 1,2, .. ,!\',aud
(3.26)
\Ve have, for each fixed €,
(3.:27)
Abo, since 1'01' all 11,
Accordillg to the LelJesguc's domiuated couvergellce tlJr'on'llI,







Condition 2. Pm' k = l, ... , !\'. (/,8S1L1IW the f'8tiollLtil/.!J ('(/lw/ioU8 80.ti-,!IJ the Ji,flowill.'l
('()(ldiliO'll8
1. cl ('O'll:lIen/I!S to som.1! I;"II:iI. 11.8 I/. ---t 00, lI.ud cl m'p' II~-(·O·II ..si8te1/.t (·st·;"IIIt.f.II1·,,/m
28
Theorem 1. Under 'II/.ild /'clJlllal'ity rondifions. and Conditioll.(1) awl COllllifion(2).
lIIellll.'IIe/OI'I.:=(I, ... ,I\")·
P(.r",,= 1)-; ,\" P(.I'",,=lIF"-I'~".I=C) 'Tr,({3,C) 11 ..' (:UI)
and
FII.7'f/I.CI', let
Var = diag(Var 1 , ••• , Va1,K)
E = diag(A) -ATA+2t(-~'~)Val"(*)'"
TII<:n
.;;; (~ - A) v N(O, E), .,fIi (.e" - (3) ~ N(O, Val') (:.U:I)




For uotation sitnplicity, lVedrop the superscript kin theest.illlutingeqllation (J.G)
front all the tenn except for f3k and .ril- for the Inolnent, aud nse .ril-- f3k only to
represcutthatit isthekl/'t.reatmentth,etwearedealingwith. Then, thepstilllating
pqllation forf3k ciln he IVrit.ten as,
o= tri,~(A: R;(o)Ah-t(Y; - J.L;)
= t·Cil-D;V,(O)-t s;
=t U;(f3\O) (J.J5)
Let. //, denote t.he solution to t.he (·stimat.iou equatiou (J.J5), uud"r t.h(~ first. IPrIll
in Condition 2, IVhpn t.herei\l"cn patient.sin the trial. Thereexislsc >0, sllch t.lmt
0= t Ui(J3~, &(J3~))





alld iJUi(fJ,:'u0«(Jk» ilrP lillPal' cOlllhillllt.ioll~ of Yi - J.l,i, thl' expectatioll of Yi - l.Li g;iVl'1l
~i is 0
\\'ehllV<'.
Thl'llllccordillgtol'l!lwtiOIlS (3.38), (3.39), (3.4U)
(3.-IU)
Fix f3k, Ilse Taylor expallsioll to expalld fllllct.ioll L:" I u;l~r,';(fJk» at It,
2:;'=1 Ui(~k.(i(f3k)) 2:;~1 U\(/3k,n) + 2:;~1 ,)u.(fJ,:;~(fJk» II~((Y _ It) +UJ!(II-~)
,,1. 1/2 J1
(:U2)
fora JII-collsistClIt estilllatorofn. JII{ii -It) =O/,(l).
Thl'reforl',
Accordillg toeqlliltiolls (:1.37), (3.<ll), (3.-13)
Write
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For Ill::; H, 11'(' hav('
E(,\["19,,,) = E(f).r'kD;ViIDi - E(.rikD;Vi 1D;j9i_I))!9",)
= ~ E(.ri,•.D;V;- I D i I9".) - ~E[E(.ri.kD:V;-IDiI9i_I)19",1
= i=~1 E(.rikD :V;- ID i I9",) + t·r"D;Vi1Di
- i=~l E(.r".D:V;- l D i I9",) - t E(./:"D;Vi 1D;j9i-1)]
= t[./:ikD;ViIDi - E(rikD;Vi 1D;j9i_I)]
= 11[",
Accordiug to t.ht'd('fiuit.iou, 1\{" isa llti1rtiugalc, aud
6 JIli = Jl[i -JI[i-1
isalltartiuga!edifferpuce
Uudl'rthc fomt.h tertu iu C'ouditiou2,
(:.1 ..16)
(:.1 ..17)
Accordiug to thp law of large utlluhers for Iltartiuga.les. ~IIJ" -'I 0 with prohahility l.
From klllllm 1. B~ cOllvrrges almost s1l1"ply to B k Thlls wc have
t .r,ID;V;-l D i = t E(.L'iID;V;-l DdQi-,) + 0(/1)
=t E(E(.rikD;V;-lDiIQi-l·~·i)) +u(/I)




Un(lPr tlte liftlt teml ill COllditioll 2, mat.rix B~ and B k arc nOllsillglllar. SlIhstit.lIt<'
(''1 l1at.ioll(3.40)illto(3..t4),
.j/i.({3k - /31,,) = (~t E(7Id{3~_l'~i,tlD;V;-lDi))-1 L;~l ~:i/3k,a) +o(/I-~)
= (B~)-l L;~l ~:i/3k, a) + o(n-~)
= ~(Bl')-l ~.r'kD;V;-lSi +0(/1-4)
CI.50)
Let
Q".k = (Bl')-l ~.ri.lD;V;-lSi'




fJk - fJk = ~(Bkr' ~.ri,.D:V;-ISi +0(11-1)
= ~Q",k + o(n-1)
Thereforp,
E(6 Q",kI9,,-I) = E(.r"k(Bk)-lD;y;;-'s,,19"_I)
= E( E(J:",k(Bk)-1 D;,v.;- I S,,19,,_I, ~,,))
= E(7r",kE((Bk)-lD;,V.;-LS,,19"_I'~"))
=0
Forlll:::::ll, it holds that






That is, Q" is a Illartingale, and {6 Q",k,9".1I 2: l} is it lnartingale diH{-n'n('('
S('qll('llce. Under t1lP fifth tPrIn in Conditioll 2,






,~ £(6 Q,,,,k 6 Q:",k)
,s f; £(6 Q~,)
=O(.jIi)
(:3,57)
according to the iterated lawoflogarithlll for 11 Iarti ngalcH,
Q..,k=O(JIIIo()IO()/I)
Th('I'l'fore, froln (J,5J)






Tht'n [n.k i~ a lIlartingale 'We n~e 6 [",t· = I",k - I,,-I,k = .In,t· - E(.I",kIF,,_I) 10
denote the lIlartingale difference, Hnd 1" = (In,I,' ,I",,,,). Since 116 [",kll ;::; 1,
111n l1 2 = fi(i:6
,-------
= ~ E((,~ 6 I".)(~ 6 I",)')
I " " 0.
= ~ E(,~ 6 I", 6 I;" + 2,~.~. 6 1",6 Ij)
= ~ ,~E(6 I", 6 I;,,)
= ~ ,~ f; E(6 I~"k)
Therdore, 111,,112 = O(.fiI)
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(:161)
According to the law of the iterated logarithm for martingales,
f,,=O(VlIloyloYII)
roreachk= 1.2 .,f\-, notice that.rHI,k can he \\'ritten as
(3.62)
Then
= E(ruIFo) + ~(ri.k - E(:ri"IF,_I)) + ~Yk(t3;)
= E(.ruIFu) + I"., + ~9k(t3i)'
Therefore
=1"'k+~(.'Ik(t3i-l)-.'Ik((3))
= f".k + ~[(t3i - (3)(~ f + o(IIt3'i - (311 1+,1)]
= I",d ~t(t31-(3i)'I'(fJ/J;f + ~O(IIt3i - (311 1+J )
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Subst.itute(3.53) iutotheaboveequatiou (3.65),




n I,' Q;." 8g " I
N" - nA = In +8 f;(--t) 1(i5j3J)1 +o(n')
=In +~t(6Q;J\~')"~~+0(/I~)
From equatious (3.67) alld (3.62), "'e have
".8. (3.67)
N n - nA = O( JI//o.'llo.'ll/) +t t O( 1/I~~.'I/0!J1/I)
..,=1 )=1 (:I.li8)
ThpI'pforp,
~ _ A = O( 1().'I~~.'In)
FrOlu<'quatious(3.59)alld(3.tm),wehaveproVl'def(uatioll(3.32)
Accordiug to conditiou 1, t.hl' cOlltilluity of the allocat.ioll fUllctioll TC" alld the
('(pmtioll 3.32. l'quatioll 3.31 C,lU be proved.
N('xt, to prove the asymptotic uOrJllalit.v of the ('stimator of rl'gr('ssioll pamlll-
del's alld t.hl' allocatioll proportion, we first Ilotice the l'quat.ioll (3.50). A('('ordill1-\
to t.he cCIlt.ral limit theorl'llI, ,IS 1/ --t 00, /I~U3k - f3k) has all asymptotic NOrJIl,1!
distrihlltinllwit.hnleanOil!Hlvariance-covariancelllil.trixVar·k where
Vark = .!~l~Co/}( 2:;::, (Bk):;U;({3k, a))
= ,!~~ ~co/}(tr;dBkrlD;V;(a)-ISi)
= "lin~~{E[(t·r;..(Bk)-lD;V;(a)-lSi)(t·,,;,(Bk)-lD;V;(a)-ISi)'I
- E(tr".(Bk)-lD;V;(a)-l S;)E(t .r;,(Bk)-lD;Vi(a)-l Si)'}
= ..'~~~ tE[E(:rf.,(Bk)-lD;V;-lSiS:V;-lDi(Bk')-l)lgi_l'~;]
= ..'~~ ~t E[(Bk)-lD;V;-lE("f,lg;_"~i)E(SiS;lg'i_r,~i)V;-lDi(Bk)-ll
= ,!~~* tE[7l"dt37_1,~;)(Bk)-ID;V;-lVII.I"(Y;I~;)VilDi(Bkrll
= (B'T' E[rr,({3, ~r)(Dk)'V-lCO"V(YI~r)V-l Dkj(B'r'
(:1.70)




Finally. we provc .,fii (~ - 1\) ~ N(O, E). Since





E(6 I""d' 6 Qm)Qm-tl












i=1 j=1 i3 m=i
= L;:i L;~, L~~' ~(f$)\iIl.I'((Bj)-IU;(i3j,a))(-!!!1d·
---t 21/(L~~,(f$)\i(//j(f:;-rr))
\1111'(1,,) = ~ diag(g(,6'i)) - g(,6. )'g(,6;)
---t l/(diag(A) - A'A)
Let L: = diag(A) - A'A + 2 L:~~l (-!!/fr )\ill.l'k(~ )'1', tl"'1I
(3.77)
, ,. '" 8g k 8g 'I'
\l1I.1'(N" - nA) = l/(dzag(A) - A A + 2 {;(iJI3k)\i1l.1' (iJI3k) ) + 0(1/) (;I7S)
= 1/L:+O(n)
Since N" - nv arp linpi1r cOlllbinations of zpro Illpan nlnrtingaks with bonnd"d vari-
Hnce, by thecpntral lilllit theorem forlllartingalps. \\"phave
.;n(~ - A) = n- 4(N" - nA) ~ N(O, E). (3.79)
Eqnation (3.33) thns isprovpd 0
3.4 Comparison Between the Extended General
CARA and the General CARA Design
Weutilizpdawidlyapplicahleestilllationapproachtoestilnatethl'longitndinaldata
accrllpd in clinical stndil'SHnd extended thpgcnprnl CAIIAdpsign (L-X Zhangl't. aI.,
2U07)tondapttotllt'trialswithlongitndinalrpsponsps.l3pcil.lIspoftlll'longitndinal
setting, both thp conduct of the desigu and tilt' aua.lysis of the accrtlpd data ,Ire
ditferentfrollltllt'originaldesign
FirstlY,omextpnded,ksignl)(,cOlllpsnlllchlllorpconlplicatpddm'tothprpppatl'd
pXiUninpddata. Whpuaupwpatiputpntprsthplrial, thpCOlllpktp inforlllation of the
previousT-l piltients have not been obtained yd. aud thpy haw to beobsn\'l'd
andrpcordedatthl'SHlnctilllcastheul'wpatiputhpiugohserved.InHddition,lh,'
probabilityofanpwpatipntbpingassignpdtoeachtreatlllputdepeudsonthp('sli-
lnntpd value of the parallletpr {3 = ({311, ... ,(3K'). Iu the CAIIA cksigu with ()Ill'
tillle r('sponsp, only one parnllletl'rallloug the Kofthelll is updated frulll the iufor-
uliltion of pn'viously treated pat.ients. VVhile in d('sign with longit.udiual I"('SIH)llS('S,
thl'recanbelllorcthanonepara.lllt'terupdatedfwnlt.h('inltJrlllationofthepl'cviuus
spvcral patipnts whose responscsand covmiatps arc lll('asur<'d reppat.edly \Vith 1"('-
IH'Med mcasmelnellt~, InOl'e information arc available li)r th~' adaptation of trealtnent
allocatioll~
Secolldly, the re~lIlt of the general CAflA de~ign call only be applied to clinical
studie~ \\'ith Ulle-time re~ponse~. This thesi~ extl'nded the r('Sult of Zhang pt al. to the
lougitudinal c1iuical triab. After careful stndy of somc wi(IPly applicable mdhOfb for
t.he longitlldinal dMaaualy~is.wc choose thegencralihed estimating ('(l'lations (Liang
and Zcger, 1!J8G) to analyze the longitudinal dat.a accrued in the clinical trials, and
sncce~~fnlly dl'rivl'd t.he nsympt.otic proflertie~ for om dl'~ign \,Vhen t1H'rl' ,Ire only





which is the casc wh('n the generalized linear nlodl'b arc nSl'd iu thc sequcntial esti-
mat ion ofZhi1nget al.'sgeueral CAflA desigu
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3.5 Comparison Between the Extended General
CARA and the other Designs with Longitu-
dinal Responses
Ati diticntist'd in ticctiun 1.1.-1, the CALflA detiign (l3itiwati ct. al.. 2(10) iti the only
opt.imal dctiign, t.o Olll" knuwlcdgc, fur longitndinal clinical trials that. consider thl'
cuvariateti uf both t.hc prcvionti pat.icntti and the ClnTl'nt pat.ient. COlllparl'd to t.11l'
CALflA design, Olll" ext.ended gencral CARA design can target allY dl,tiired allocat.ion
proportion whereas t.he CALflA dcsign can only t.mget. a certain optimal a,llocat.ion
proport.iun decided by t.hc nt.ilit.y fnnction they defilled, In addit.ion, thc l'xt.l'n,kd
CAflA design can be applied t.o clinical t.rials with lIlon' t.han t.wo cOlnpet.ing trl'nt.-
llIl'nh and any retiponses which follow adistril)lltion in the l'xponent.ial falllily. To




Conclusions and Future Work
\'Ve h'lVe COlldlleted a review on t.he developllll'lIt. of n'spulIse-adapt.ivc ral\(lOIlIiza-
tion.i1l\(lhavedisclIssedt.hellec('ssityofrf'Sj)(lIlsc-adaptivl'desigllwithlulIgitlldillill
respoIIses. Thf' collt.riblltioll of this resf'<lrch is thnt. w(' proposed i1 gellPral CAflA
desigll for IOllgit.lldillnl clillical trinls which extellds the fralllework of the CAflA dl L
sigil by Zhallg et i11.(2007). Om lksign cOIIsiders the covariate illfunllatioll of both
the previuus patiellt.s ill the stlldy i1l1d t.he CII!Tellt patiellt wbo is reildy for trl'at-




the regrl'ssioll pilnllllet.ers alld the allocation propurtioll. The explicit furlll of the
variabilityufthenllocat.iollproport.ionisillsoubtailled.
Thereill'estillproblrlllslcft.forfmt.herresenrch. The'lllocatioll fllllCtiOIl which is
directly r<dated to the vill'iabilit.yufthenllocat.ioll propol'tiullllldy hns age!H'ral fonll
in Ollr design. r-Ion'stndies ar(' n('('(kd to lind >llloc>ltion fnnctions which will resnlt
in slll>lll('r variahility for the d('sign. or to look into optilll>llity criteria for '1I1 optiln>ll
>lllocation fnnction thatp;ivesth(,slllnll('st variahility. Also, th('design \W'proposed
r('qnin'sthntth('r('sponsesof('achpati('ntarecolllplet('orlllissingcolnpktl'!y,lt ran-
dOlll (r-ICAR) (C'ornfi('ld, 1959). The COlll'cting tilll(, point for 10llgitndinill n'sponSl'S
ar(' >lssnlned to 1)(' eqn>llly spaced ilS well. However, in prilctic<" oft(,1l SOl Ill' p>lli('nls
drop oH' th(' trial IJl'for(' theircolllpkte respons('s me colled('d, or tlll'n' nIay h('d('-
lay('d respons('s frolll SUlnc patients, or the repeat('d In(',lSllrCllI('nt ofl'ach pati('nt 'In'
nllr('alistic to he ('qnally spaced. Littlc is known ahollt n'sjwns('-adaptiv(' randOlniza-
tionwith 101lgitndinal reSpOIISl'S whl'nlllissingdatn with ('('rtain patt('rt1 pn's('nt, and
whl'n th(' n'I)('i\t('dln('asnr('lnent are not ('qnally spac('d. Getter Illcl'hods ill ,nlalyzing
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5.1.1 General Definition and Properties of Martingales
Definition 1. L<'I (n. F, P) be (l fJmbability sfJnce: \l is It sel. F n l7-jirld oJ slIbs<'Is
oJ n. III/ll P n fJl'Obllbilillj 1/1.N!SII:re defined OIL F. Let [ be nl/Ij il/lervnl oJ 11". jiJl'III
(1/.1»).[II,").(II,blor[II,"]oJI"eorden~d.w,t{- , .. ,-l,ll.l, ... oo}. L<'I{F",I/E
f} be ILl/. inU"et1si/l,!J sl'qnence oJ a-fields of F sets. SnfJpose t"nl {Z". 1/ El} is n
s/'lfnel/a of nwdollL Ufwinbles on \l snti.sfyinq
1. Z" is 1/1 {'(LSnmblelIJith're8prcl10F"
2. EIZ"I <
3. E(Z" IF,,,) = Z", II..S jin' nil Ill. < /1" 111., nE 1
The1l. the seljl!/'ncl' {Z,,, 11 E f} is sl!irl to be fl1lUL7·ti71.'/ale with I"I'Sj)('et to {F,,, 11 E f}
We wl"ite thflt {Z,,,F,,,II EJ} is a IIIfll"tin.'/ale.
Definition 2. A seljl!ence P~" g". 11 ;;, 1) rll'fi7/1'11 on (11, F, P) i.s mtLl'lf I/. 1II1II"ti.'/II(1I,·
dijj"ewIII'e Sl'ljllenr:/' -if g" C Far/' i'llr:rl'f!si71g a-fieltls with};, b,'-illg g" III1'as(ll'IIblc I/.IlIf
EP;,!9,,) =Ofol" all n;;' 2.
5.1.2 Useful Theorems of Martingales
Theorem 2. (LI!'/II of L!!'/ge NI!'III,be'l"s fO'1" MII.7·t'ingl!lr:s):





For each j = 1, ,11, Id. S".. be a martingale with respect. to nested siglna-
algebras F" ... Let X" .. = S".. - 5","-1, S"o = 0, denote the martignalc diH'er('n('('s
Then {S" .. ,F"d, for k = 1, ,11. 11 ~ 1 is a donble S(''1l1('lIce of trinllglllar arrays.
called a martingale army (Hall and Heyde(1!J80)). The (;(,lItrallimit. t.h('oreln for
llIartingalearrnys {S"",F",.} states as bclow.
Theorem 3. (lJillinljs/ey's Centml Limit Thmrem)




~ 1/,-1-.1/1t E(lXj I2+.1IFj _tl = °
fo,. positive l'ol/811l11.IsO allllq1, Th('n
I/-~ t .Yj ~ N(O,I/)
)=1
Theorem 4. (Law of the !ll'mtl'd LOljarilhm fo'" A!a,.lil/,ljlll"8)-
(G,-I)
(:"'i,G)
Let (Z".F", I/ ;;: 1) be a 'IIIa,,.lin.'lalc defined un 11. probability space (n.F,p) ",ilh
and 11" = J2lolJlo.'ls?" [f8~, -t 00 and
IY"I:,::: 1\018"/11,, fa,. 1/,:::: 1
",hNc [\'" al'e F"_l '111.el/..~u.mble and [\'" -t 0, I!wl/,liIllSlIpZ"/(S,,II.,,) = 1
(G(i)
If IY",I :'::: 1\' fur SOIllE' constant [\' alld ,,~, -t ,thC'1I the law of the itC'l'iltC'd
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